Package Leaflet: Information for the User
Decapeptyl Daily 0.1 mg Powder and Solvent for Solution for Injection
Triptorelin
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack and other information:
Contents of the pack and other information
This medicine contains triptorelin. Triptorelin belongs to a group of medicines known as gonadotropin-releasing hormone (GnRH) analogues. One of its actions is to decrease the levels of sex hormones in the body.
Decapeptyl Daily is indicated in women, for the treatment of female infertility, as a complementary treatment associated with gonadotropins (HMG, FSH, HCG) during ovulation induction for in vitro fertilization and embryo transfer (IVF-ET).
Do not use Decapeptyl Daily:
Warnings and precautions:
Depression has been reported in patients treated with Decapeptyl Daily, which can be severe. If you are being treated with Decapeptyl Daily and you experience depression, inform your doctor.
If you have an unknown benign tumor (adenoma) of the pituitary gland, this may be discovered during treatment with Decapeptyl Daily. Symptoms include headache, visual problems, and paralysis of the eyes.
In adults, triptorelin may cause bones to become less dense (osteoporosis) with an increased risk of bone fractures. Therefore, inform your doctor if you have any of the following risk factors:
If you experience seizures, inform your doctor immediately. Seizures have been reported in patients treated with triptorelin or similar medicines. These occurred in patients with or without a medical history of epilepsy.
During fertility treatment, gonadotropins (hormones that stimulate the ovaries) combined with this product may induce an increase in ovarian size or cases of ovarian hyperstimulation syndrome (abnormal production of eggs leading to fluid accumulation in the abdominal area, causing swelling and pain, and difficulty breathing). If this happens, consult your doctor immediately.
Patients receiving this treatment should be under close medical supervision with regular radiological, clinical, and biological checks.
Consult your doctor if you are concerned about any of these issues.
Other medicines and Decapeptyl Daily
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines, including those obtained without a prescription.
Pregnancy and breast-feeding
Decapeptyl Daily must not be used during pregnancy or breast-feeding.
If you discover that you are pregnant while taking this medicine, inform your doctor immediately so that the treatment can be discontinued.
Driving and using machines
You may feel dizzy, tired, or experience vision problems, such as blurred vision. These are possible side effects of the treatment or the underlying disease. If you experience any of these side effects, do not drive or operate machinery.
Decapeptyl Daily contains sodium
This medicine contains sodium, but less than 1 mmol (23 mg) of sodium per vial; this is essentially "sodium-free".
Follow exactly the administration instructions of this medicine as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Decapeptyl Daily must be administered exclusively by subcutaneous route (under the skin).
The dose will be established by the doctor based on the needs of each patient. The usual doses are as follows:
Short protocol: One subcutaneous injection of one vial of Decapeptyl Daily 0.1 mg from day 2 of the cycle (concurrently with the start of ovarian stimulation) until the day before the planned induction. The average duration of treatment is 10 to 12 days per cycle.
Long protocol: One subcutaneous injection of one vial of Decapeptyl Daily 0.1 mg from day 2 of the cycle. When pituitary desensitization appears (E2 <50 pg ml) approximately on day 15 after the start of treatment, gonadotropin stimulation is initiated while continuing administration decapeptyl daily 0.1 mg until before planned induction. duration this treatment can be 18 to 25 days per cycle.< p>
If you use more Decapeptyl Daily than you should
No cases of adverse reactions due to overdose have been reported.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20.
If you forget to use Decapeptyl Daily
Do not take a double dose to make up for forgotten doses.
If you stop treatment with Decapeptyl Daily
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Decapeptyl Daily 0.1 mg can cause side effects, although not everybody gets them.
Many of the side effects are expected due to the change in testosterone levels in your body. These effects can include hot flashes, impotence, and decreased libido.
In rare cases, you may experience a severe allergic reaction. Consult your doctor immediately if you develop symptoms such as difficulty swallowing or breathing, swelling of the lips, face, throat, or tongue, rash.
If you have an unknown benign tumor (adenoma) of the pituitary gland, this may be discovered during treatment with Decapeptyl Daily. Symptoms include sudden headache, vomiting, vision problems, and paralysis of the eyes.
As with other GnRH analogues, an increase in white blood cell count may occur in patients treated with Decapeptyl Daily.
Many of the side effects are expected due to the change in estrogen levels in your body.
Very common side effects (affect more than 1 in 10 people):
Common side effects (affect 1 to 10 people in 100):
Uncommon side effects (affect 1 in 100 to 1 in 1,000 people):
During post-marketing surveillance, the following side effects have also been reported (their frequency cannot be estimated from the available data):
During fertility treatment, gonadotropins combined with this product may induce abdominal or pelvic pain or difficulty breathing. If this happens, consult your doctor as soon as possible.
Reporting of side effects
If you experience any side effects, talk to your doctor, even if they are not listed in this leaflet. You can also report side effects directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: http://www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Store Decapeptyl Daily in its original package.
Store below 25°C.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date is the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Decapeptyl Daily
The active substance is triptorelin (acetate), 0.1 mg per vial.
The other ingredients are:
Appearance of the product and contents of the pack
Each pack contains:
Marketing authorization holder and manufacturer
Marketing authorization holder:
IPSEN PHARMA, S.A.U.
Gran Via de les Corts Catalanes 130-136
08038 Barcelona
Spain
Manufacturer:
Parc d'Activité du Plateau de Signes, C.D. 402,
83870 Signes
France
Date of last revision of this leaflet: February 2025
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es